Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ovarian cancer
Pharma
FDA endorses Merck's Keytruda for the 1st time in ovarian cancer
Thirteen years after the FDA first blessed Keytruda for melanoma, the agency has approved the PD-1 superstar for a certain type of ovarian cancer.
Kevin Dunleavy
Feb 11, 2026 10:04am
Expert testimony will be allowed in J&J talc litigation in N.J.
Jan 21, 2026 5:00pm
J&J will appeal $1.5B verdict in record-breaking talc award
Dec 23, 2025 11:06am
AZ faces FDA challenge as Imfinzi-Lynparza miss survival goal
Oct 19, 2025 4:15am
ESMO: Merck lays out Keytruda's landmark win in ovarian cancer
Oct 18, 2025 10:30am
In ovarian cancer, Keytruda follows PFS win with survival showing
Oct 16, 2025 10:23am
